Ultrasonography to quantify hepatic fat content: Validation by 1H magnetic resonance spectroscopy

Obesity

Volumn 17, Issue 12, 2009, Pages 2239-2244

  Edens, Mireille A ^a   Van Ooijen, Peter M A ^a   Post, Wendy J ^a   Haagmans, Mark J F ^a   Kristanto, Wisnumurti ^a   Sijens, Paul E ^a   Van Der Jagt, Erik J ^a   Stolk, Ronald P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; ARTICLE; BIOLOGICAL MODEL; BODY MASS; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; LIVER; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PATHOLOGY; VALIDATION STUDY;

ADIPOSE TISSUE; ADULT; BODY MASS INDEX; FATTY LIVER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY; SOFTWARE; ULTRASONOGRAPHY; YOUNG ADULT;

EID: 72449176355     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.154     Document Type: Article

References (37)

1. Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
2. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
3. Ekstedt M, Franzén LE, Mathiesen UL et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865-873.
4. Smedile A, Bugianesi E. Steatosis and hepatocellular carcinoma risk. Eur Rev Med Pharmacol Sci 2005;9:291-293.
5. Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:27-38.
6. Edens MA, Kuipers F, Stolk R P. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. Obes Rev. 2009 Apr. 1 (e-pub ahead of print).
7. Mills SJ, Harrison SA. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Curr Gastroenterol Rep 2005;7:32-36.
8. Bedogni G, Miglioli L, Masutti F et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005;42:44-52.
9. Volzke H, Robinson DM, Kleine V et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005;11:1848-1853.
10. Szczepaniak LS, Nurenberg P, Leonard D et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288:E462-E468.
11. Friedman JM. Obesity in the new millennium. Nature 2000;404:632-634.
12. Araya J, Rodrigo R, Videla LA et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci 2004;106:635-643.
13. Puri P, Baillie RA, Wiest MM et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007;46:1081-1090.
14. Irwan R, Edens MA, Sijens PE. Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging. Eur Radiol 2008;18:806-813.
15. Duman DG, Celikel C, Tüney D et al. Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment? Dig Dis Sci 2006;51:346-351.
16. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986;292:13-15.
17. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991;43:26-31.
18. Smith-Levitin M, Blickstein I, Albrecht-Shach AA et al. Quantitative assessment of gray-level perception: observers' accuracy is dependent on density differences. Ultrasound Obstet Gynecol 1997;10:346-349.
19. Gaitini D, Baruch Y, Ghersin E et al. Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter. Ultrasound Med Biol 2004;30:1321-1327.
20. Mendler MH, Bouillet P, Le Sidaner A et al. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 1998;28:785-794.
21. Szczepaniak LS, Babcock EE, Schick F et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999;276:E977-E989.
22. Sijens PE, Smit G P, Borgdorff MA, Kappert P, Oudkerk M. Multiple voxel 1H MR spectroscopy of phosphorylase-b kinase deficient patients (GSD IXa) showing an accumulation of fat in the liver that resolves with aging. J Hepatol 2006;45:851-855.
23. Thomsen C, Becker U, Winkler K et al. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994;12: 487-495.
24. Vuppalanchi R, Cummings OW, Saxena R et al. Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples. J Clin Gastroenterol 2007;41:206-210.
25. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
26. Graif M, Yanuka M, Baraz M et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000;35:319-324.
27. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-3004.
28. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132-138.
29. Joseph AE, Saverymuttu SH. Ultrasound in the assessment of diffuse parenchymal liver disease. Clin Radiol 1991;44:219-221.
30. Mazzone AM, Urbani M P, Picano E et al. In vivo ultrasonic parametric imaging of carotid atherosclerotic plaque by videodensitometric technique. Angiology 1995;46:663-672.
31. Yin M, Woollard J, Wang X et al. Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography. Magn Reson Med 2007;58:346-353.
32. Merriman RB, Ferrell LD, Patti MG et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 2006;44:874-880.
33. Zhang J, Tan T. Brief review of invariant texture analysis methods. Pattern Recognit 2002;35:735-747.
34. Haralick RM. Statistical and structural approaches to texture. Proc IEEE 1979;67:786-804.
35. Horng MH, Sun YN, Lin XZ. Texture feature coding method for classification of liver sonography. Comput Med Imaging Graph 2002;26:33-42.
36. Gotlieb C, Kreyszig H. Texture descriptors based on co-occurrence matrices. Comput Vis Graph Image Process 1990;51:70-86.
37. Prakash KN, Ramakrishnan AG, Suresh S, Chow TW. An investigation into the feasibility of fetal lung maturity prediction using statistical textural features. Ultrason Imaging 2001;23:39-54